Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism

• Main Authors: Xin Qiao (Author), Zhuo-Chao Zhou (Author), Rui Niu (Author), Yu-Tong Su (Author), Yue Sun (Author), Hong-Lei Liu (Author), Jia-Lin Teng (Author), Jun-Na Ye (Author), Hui Shi (Author), Cheng-De Yang (Author), Xiao-Bing Cheng (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The burden of obesity and associated cardiometabolic diseases has been considered as an important risk factor for lupus patients. Therefore, whether obesity is involved in the over-activation of autoimmune response has attracted more and more attention. Hydroxychloroquine is a synthetic antimalarial...